Raaj Medisafe India Upgraded to Higher Quality Grade Amid Strong Growth Metrics

Raaj Medisafe India, a microcap player in the medical equipment and supplies sector, has recently undergone an evaluation revision reflecting its performance metrics. The company has demonstrated notable sales growth over the past five years, achieving a rate of 55.74%. Additionally, its EBIT growth during the same period stands at 50.96%, indicating a strong operational performance.
Financial stability is underscored by a favorable EBIT to interest ratio of 3.05 and a negative net debt position, suggesting that the company is managing its liabilities effectively. The net debt to equity ratio is reported at 4.48, while the sales to capital employed ratio is 1.43, highlighting efficient use of capital.

In terms of profitability, Raaj Medisafe boasts a return on equity (ROE) of 77.24% and a return on capital employed (ROCE) of 4.74%. The tax ratio is noted at 30.35%, and the company has no pledged shares or institutional holdings, indicating a strong ownership structure.

When compared to its peers, Raaj Medisafe stands out with its robust growth metrics, while several competitors are positioned below average in quality assessments. This context emphasizes Raaj Medisafe's competitive edge within the medical equipment industry.